Whether an audit finding is a program-wide failure from return-to-duty

Situation

An audit finding is sits with DOT program-design consultant because a B bottle that arrived warm and unlabeled hit a company transitioning to oral fluid. Evidence is return-to-duty follow-up testing calendar; write the Forensic Drug Testing Specimen Validity option that extract can carry.

Decision

DOT program-design consultant in a company transitioning to oral fluid must choose Accept the result / Reject on custody / Recollect / Hold using return-to-duty follow-up testing calendar after a B bottle that arrived warm and unlabeled.

Hypotheses to test

• DOT program-design consultant can defend Accept the result from return-to-duty follow-up testing calendar after a B bottle that arrived warm and unlabeled in a Forensic Drug Testing challenge.
• DOT program-design consultant cannot defend Accept the result from return-to-duty follow-up testing calendar; Reject on custody is what the extract actually supports after a B bottle that arrived warm and unlabeled.
• A B bottle that arrived warm and unlabeled never reached the population in return-to-duty follow-up testing calendar — reopen intake, do not close an audit finding is.
• Two facts in return-to-duty follow-up testing calendar after a B bottle that arrived warm and unlabeled conflict for DOT program-design consultant; hold this Specimen Validity file.

Analysis required

• Test whether a broken seal, timing miss, or donor explanation changes an audit finding is.
• Confirm the kit ID in return-to-duty follow-up testing calendar matches the collection log.
• Check MRO notes and cutoffs against the protocol a company transitioning to oral fluid claims to run.
• For this Forensic Drug Testing Specimen Validity file, read return-to-duty follow-up testing calendar against a B bottle that arrived warm and unlabeled and write the one fact that would move an audit finding is for DOT program-design consultant.

Recommendation

DOT program-design consultant owns an audit finding is on return-to-duty follow-up testing calendar in a company transitioning to oral fluid. After a B bottle that arrived warm and unlabeled, choose Accept the result / Reject on custody / Recollect / Hold using only what this Forensic Drug Testing Specimen Validity packet proves. If return-to-duty follow-up testing calendar is silent on the discriminator after a B bottle that arrived warm and unlabeled, DOT program-design consultant must do not accept, reject, or recollect beyond what custody and validity support rather than reuse a label from another Specimen Validity packet.